Oppenheimer analyst Michael Wiederhorn maintained a Hold rating on Envision Healthcare (NYSE: EVHC) yesterday. The company’s shares closed yesterday at $44.65.
According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 16.6% and a 73.1% success rate. Wiederhorn covers the Services sector, focusing on stocks such as Cross Country Healthcare, Addus Homecare Corp, and Community Health.
Currently, the analyst consensus on Envision Healthcare is Moderate Buy and the average price target is $47.20, representing a 5.7% upside.
In a report released yesterday, William Blair also downgraded the stock to Hold.
See today’s analyst top recommended stocks >>
Envision Healthcare’s market cap is currently $5.41B and has a P/E ratio of 48.22. The company has a Price to Book ratio of 0.84.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Envision Healthcare Corp. engages in the provision of healthcare services. It operates through the Physician Services and Ambulatory Services segments. The Physician Services segment provides hospital-based and non-hospital-based physician services business.
